Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition: Unmasking and Masquerading.

Francis JH, Berry D, Abramson DH, Barker CA, Bergstrom C, Demirci H, Engelbert M, Grossniklaus H, Hubbard B, Iacob CE, Jaben K, Kurli M, Postow MA, Wolchok JD, Kim IK, Wells JR.

Ophthalmology. 2019 Sep 24. pii: S0161-6420(19)32085-8. doi: 10.1016/j.ophtha.2019.09.018. [Epub ahead of print]

PMID:
31708274
2.

Impact of enucleation on adult retinoblastoma survivors' quality of life: A qualitative study of survivors' perspectives.

Banerjee SC, Pottenger E, Petriccione M, Chou JF, Ford JS, Sklar CA, Robison LL, Kleinerman RA, Oeffinger KC, Francis JH, Abramson DH, Dunkel IJ, Friedman DN.

Palliat Support Care. 2019 Nov 8:1-10. doi: 10.1017/S1478951519000920. [Epub ahead of print]

PMID:
31699178
3.

Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.

Zauderer MG, Jayakumaran G, DuBoff M, Zhang L, Francis JH, Abramson DH, Cercek A, Nash GM, Shoushtari A, Chapman P, D'Angelo S, Arnold AG, Siegel B, Fleischut MH, Ni A, Rimner A, Rusch VW, Adusumilli PS, Travis W, Sauter JL, Zehir A, Mandelker D, Ladanyi M, Robson M.

J Thorac Oncol. 2019 Nov;14(11):1989-1994. doi: 10.1016/j.jtho.2019.07.002. Epub 2019 Jul 16.

PMID:
31323388
4.

A Potential Role For Apparent Diffusion Coefficient in the Diagnosis of Trilateral Retinoblastoma.

Farouk Sait S, Haque S, Karimi S, Rebeiz KJ, Francis JH, Marr BP, Abramson DH, Souweidane MM, Dunkel IJ.

J Pediatr Hematol Oncol. 2019 Jun 27. doi: 10.1097/MPH.0000000000001523. [Epub ahead of print]

PMID:
31259824
5.

Spectrum of Disease Severity and Phenotype in Choroideremia Carriers.

Jauregui R, Park KS, Tanaka AJ, Cho A, Paavo M, Zernant J, Francis JH, Allikmets R, Sparrow JR, Tsang SH.

Am J Ophthalmol. 2019 Nov;207:77-86. doi: 10.1016/j.ajo.2019.06.002. Epub 2019 Jun 8.

PMID:
31181178
6.

Chemoreduction of Orbital Recurrence of Uveal Melanoma by Intra-Arterial Melphalan.

Francis JH, Barker CA, Yin VT, Carvajal RD, Chapman P, Abramson DH, Gobin YP.

Ocul Oncol Pathol. 2019 Apr;5(3):186-189. doi: 10.1159/000490061. Epub 2018 Oct 9.

7.

Intraocular B-cell Acute Lymphoblastic Leukemia.

Francis JH, Orlin A, Stein EM.

Ophthalmol Retina. 2018 Aug;2(8):826. doi: 10.1016/j.oret.2018.03.002. Epub 2018 Aug 2. No abstract available.

PMID:
31047536
8.

Iris Mass in a 2-Year-Old.

Abramson DH, Dhar LS, Francis JH.

Ophthalmol Retina. 2018 Sep;2(9):905. doi: 10.1016/j.oret.2018.06.010. Epub 2018 Sep 4. No abstract available.

PMID:
31047223
9.

Pseudomelanoma (with Cataract) in a Child Caused by Amniocentesis.

Abramson DH, Francis JH.

Ophthalmology. 2019 Apr;126(4):590. doi: 10.1016/j.ophtha.2019.01.025. No abstract available.

PMID:
30910042
10.

What's New in Intra-Arterial Chemotherapy for Retinoblastoma?

Abramson DH, Francis JH, Gobin YP.

Int Ophthalmol Clin. 2019 Spring;59(2):87-94. doi: 10.1097/IIO.0000000000000266. Review. No abstract available.

PMID:
30908282
11.

Efficacy of MEK inhibition in patients with histiocytic neoplasms.

Diamond EL, Durham BH, Ulaner GA, Drill E, Buthorn J, Ki M, Bitner L, Cho H, Young RJ, Francis JH, Rampal R, Lacouture M, Brody LA, Ozkaya N, Dogan A, Rosen N, Iasonos A, Abdel-Wahab O, Hyman DM.

Nature. 2019 Mar;567(7749):521-524. doi: 10.1038/s41586-019-1012-y. Epub 2019 Mar 13.

12.

Trends in Radiation Practices for Female Ocular Oncologists in North America: A Collaborative Study of the International Society of Ocular Oncology.

Shah SN, Kogachi K, Correa ZM, Schefler AC, Aronow ME, Callejo SA, Cebulla CM, Day-Ghafoori S, Francis JH, Lally S, McCannel TA, Paton KE, Phan IT, Pointdujour-Lim R, Ramasubramanian A, Rath P, Shields CL, Skalet AH, Wells JR, Jennelle RL, Berry JL.

Ocul Oncol Pathol. 2019 Jan;5(1):54-59. doi: 10.1159/000489219. Epub 2018 Jun 12.

13.

Proceedings of the Association for Research in Vision and Ophthalmology and Champalimaud Foundation Ocular Oncogenesis and Oncology Conference.

Smith JR, Pe'er J, Belfort RN, Cardoso F, Carvajal RD, Carvalho C, Coupland SE, Desjardins L, Francis JH, Gallie BL, Gombos DS, Grossniklaus HE, Heegaard S, Jager MJ, Kaliki S, Ksander BR, Maeurer M, Moreno E, Pulido JS, Ryll B, Singh AD, Zhao J, Parreira A, Wilson DJ, O'Brien JM.

Transl Vis Sci Technol. 2018 Jan 9;8(1):9. doi: 10.1167/tvst.8.1.9. eCollection 2019 Jan.

14.

Association of electroretinography with visual outcomes after ophthalmic artery chemosurgery for retinoblastoma in ICRb D and E eyes.

Levin AM, Francis JH, McFadden M, Brodie S, Gobin YP, Abramson DH.

PLoS One. 2019 Jan 16;14(1):e0210647. doi: 10.1371/journal.pone.0210647. eCollection 2019.

15.

SUBFOVEAL CHOROIDAL THICKNESS AND VASCULAR ARCHITECTURE IN FELLOW EYES OF PATIENTS WITH CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.

Sobol EK, Francis JH, Abramson DH, Freund KB, Spaide RF, Barbazetto I.

Retina. 2019 Jan 9. doi: 10.1097/IAE.0000000000002438. [Epub ahead of print]

PMID:
30633085
16.

GNAQ Mutations in Diffuse and Solitary Choroidal Hemangiomas.

Francis JH, Milman T, Grossniklaus H, Albert D, Folberg R, Levitin G, Coupland S, Catalanotti F, Rabady D, Kandoth C, Busam K, Abramson D.

Ophthalmology. 2019 May;126(5):759-763. doi: 10.1016/j.ophtha.2018.12.011. Epub 2018 Dec 8.

PMID:
30537484
17.

Hepatic abnormalities identified by staging MRI and accuracy of MRI of patients with uveal melanoma.

Francis JH, Catalanotti F, Landa J, Barker CA, Shoushtari AN, Abramson DH.

Br J Ophthalmol. 2019 Sep;103(9):1266-1271. doi: 10.1136/bjophthalmol-2018-312612. Epub 2018 Oct 31.

PMID:
30381389
18.

Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007-2017.

Lu JE, Francis JH, Dunkel IJ, Shields CL, Yu MD, Berry JL, Kogachi K, Skalet AH, Miller AK, Santapuram PR, Daniels AB, Abramson DH.

Br J Ophthalmol. 2019 Sep;103(9):1272-1277. doi: 10.1136/bjophthalmol-2018-312915. Epub 2018 Oct 25.

19.

A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor.

Kelly CM, Shoushtari AN, Qin LX, D'Angelo SP, Dickson MA, Gounder MM, Keohan ML, Mcfadyen C, Sjoberg A, Singer S, DeMatteo RP, Hwang S, Heinemann MH, Francis JH, Antonescu CR, Chi P, Tap WD.

Invest New Drugs. 2019 Apr;37(2):282-290. doi: 10.1007/s10637-018-0648-z. Epub 2018 Aug 13.

20.

Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab.

Francis JH, Slakter JS, Abramson DH, Odrich SA, Gobin YP.

Am J Ophthalmol Case Rep. 2018 May 24;11:49-51. doi: 10.1016/j.ajoc.2018.05.007. eCollection 2018 Sep.

21.

Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy.

Francis JH, Roosipu N, Levin AM, Brodie SE, Dunkel IJ, Gobin YP, Abramson DH.

Neoplasia. 2018 Aug;20(8):757-763. doi: 10.1016/j.neo.2018.05.007. Epub 2018 Jun 22.

22.

Clinicopathological Correlation of Choroidal Invasion in Retinoblastoma.

Abramson DH, Folberg R, Francis JH.

JAMA Ophthalmol. 2018 Jun 14;136(6):e180940. doi: 10.1001/jamaophthalmol.2018.0940. Epub 2018 Jun 14. No abstract available.

PMID:
29902319
23.

Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds.

Abramson DH, Ji X, Francis JH, Catalanotti F, Brodie SE, Habib L.

Br J Ophthalmol. 2019 Apr;103(4):488-493. doi: 10.1136/bjophthalmol-2018-312037. Epub 2018 Jun 6.

PMID:
29875233
24.

Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival.

Francis JH, Levin AM, Zabor EC, Gobin YP, Abramson DH.

PLoS One. 2018 May 23;13(5):e0197081. doi: 10.1371/journal.pone.0197081. eCollection 2018.

25.

Choroidal infarction following ophthalmic artery chemotherapy.

Bohm KJ, Gobin YP, Francis JH, McInerney G, Dabo-Trubelja A, Dalecki PH, Marr BP, Abramson DH.

Int J Retina Vitreous. 2018 Apr 30;4:16. doi: 10.1186/s40942-018-0119-x. eCollection 2018.

26.

Growth patterns of survivors of retinoblastoma treated with ophthalmic artery chemosurgery.

Akella SS, Francis JH, Knezevic A, Ostrovnaya I, Gobin YP, Friedman D, Guarini E, Eibeler L, Catalanotti F, Abramson DH.

PLoS One. 2018 May 7;13(5):e0197052. doi: 10.1371/journal.pone.0197052. eCollection 2018.

27.

Vision-Targeted Health-Related Quality of Life in Adult Survivors of Retinoblastoma.

Friedman DN, Chou JF, Francis JH, Sklar CA, Li Y, McCabe M, Robison LL, Kleinerman RA, Oeffinger KC, Abramson DH, Dunkel IJ, Ford JS.

JAMA Ophthalmol. 2018 Jun 1;136(6):637-641. doi: 10.1001/jamaophthalmol.2018.1082.

28.

Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery.

Rowlands MA, Mondesire-Crump I, Levin A, Mauguen A, Francis JH, Dunkel IJ, Brodie SE, Gobin YP, Abramson DH.

PLoS One. 2018 Apr 26;13(4):e0195395. doi: 10.1371/journal.pone.0195395. eCollection 2018.

29.

Reply.

Francis JH, Abramson DH, Habib L, Yannuzzi LA, Catalanotti F.

Ophthalmology. 2018 Apr;125(4):e31. doi: 10.1016/j.ophtha.2017.11.002. No abstract available.

PMID:
29566879
30.

Clinicopathologic Correlation of Choroidal Invasion in Retinoblastoma.

Abramson DH, Folberg R, Francis JH.

Ophthalmology. 2018 Apr;125(4):568. doi: 10.1016/j.ophtha.2017.11.037. No abstract available.

PMID:
29566869
31.

Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma.

Abramson DH, Catalanotti F, Brodie SE, Kellick MG, Francis JH.

Ophthalmic Genet. 2018 Jun;39(3):353-356. doi: 10.1080/13816810.2018.1443343. Epub 2018 Mar 7.

PMID:
29513055
32.

BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi.

Francis JH, Grossniklaus HE, Habib LA, Marr B, Abramson DH, Busam KJ.

Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):117-121. doi: 10.1167/iovs.17-22517.

33.

Choroidal Invasion in Retinoblastoma Treated with Intrarterial Chemotherapy.

Abramson DH, Francis JH, Gobin YP.

Ophthalmol Retina. 2018 Jan;2(1):9. doi: 10.1016/j.oret.2017.08.022. Epub 2018 Jan 3. No abstract available.

PMID:
31047314
34.

Risk of Extraocular Extension in Eyes With Retinoblastoma Receiving Intravitreous Chemotherapy.

Francis JH, Abramson DH, Ji X, Shields CL, Teixeira LF, Schefler AC, Cassoux N, Hadjistilianou D, Berry JL, Frenkel S, Munier FL.

JAMA Ophthalmol. 2017 Dec 1;135(12):1426-1429. doi: 10.1001/jamaophthalmol.2017.4600.

35.

Vitreous Disease in Retinoblastoma: Clinical Findings and Treatment.

Francis JH, Habib LA, Abramson DH.

Adv Ophthalmol Optom. 2017 Aug;2(1):177-195. doi: 10.1016/j.yaoo.2017.03.008. No abstract available.

36.

Selective ophthalmic artery chemosurgery (SOAC) for retinoblastoma: fluoroscopic time and radiation dose parameters. A baseline study.

Boddu SR, Abramson DH, Marr BP, Francis JH, Gobin YP.

J Neurointerv Surg. 2017 Nov;9(11):1107-1112. doi: 10.1136/neurintsurg-2016-012758. Epub 2016 Nov 9.

PMID:
29030462
37.

Cancer Therapy with Checkpoint Inhibitors: Establishing a Role for Ophthalmology.

Davis ME, Francis JH.

Semin Oncol Nurs. 2017 Nov;33(4):415-424. doi: 10.1016/j.soncn.2017.08.003. Epub 2017 Sep 21. Review.

PMID:
28941564
38.

Growth of Uveal Melanoma following Intravitreal Bevacizumab.

Francis JH, Kim J, Lin A, Folberg R, Iyer S, Abramson DH.

Ocul Oncol Pathol. 2017 Jul;3(2):117-121. doi: 10.1159/000450859. Epub 2016 Nov 12.

39.

An international survey of classification and treatment choices for group D retinoblastoma.

Scelfo C, Francis JH, Khetan V, Jenkins T, Marr B, Abramson DH, Shields CL, Pe'er J, Munier F, Berry J, Harbour JW, Yarovoy A, Lucena E, Murray TG, Bhagia P, Paysse E, Tuncer S, Chantada GL, Moll AC, Ushakova T, Plager DA, Ziyovuddin I, Leal CA, Materin MA, Ji XD, Cursino JW, Polania R, Kiratli H, All-Ericsson C, Kebudi R, Honavar SG, Vishnevskia-Dai V, Epelman S, Daniels AB, Ling JD, Traore F, Ramirez-Ortiz MA.

Int J Ophthalmol. 2017 Jun 18;10(6):961-967. doi: 10.18240/ijo.2017.06.20. eCollection 2017.

40.

Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous Chorioretinopathy.

Francis JH, Habib LA, Abramson DH, Yannuzzi LA, Heinemann M, Gounder MM, Grisham RN, Postow MA, Shoushtari AN, Chi P, Segal NH, Yaeger R, Ho AL, Chapman PB, Catalanotti F.

Ophthalmology. 2017 Dec;124(12):1788-1798. doi: 10.1016/j.ophtha.2017.05.038. Epub 2017 Jul 12.

41.

Peripheral leptochoroid: clinical and anatomical findings.

Francis JH, Habib LA, Abramson DH.

Br J Ophthalmol. 2018 Jan;102(1):120-125. doi: 10.1136/bjophthalmol-2017-310406. Epub 2017 Jun 16.

PMID:
28625971
42.

Second primary malignancies in retinoblastoma patients treated with intra-arterial chemotherapy: the first 10 years.

Habib LA, Francis JH, Fabius AW, Gobin PY, Dunkel IJ, Abramson DH.

Br J Ophthalmol. 2018 Feb;102(2):272-275. doi: 10.1136/bjophthalmol-2017-310328. Epub 2017 Jun 9.

PMID:
28600304
43.

Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.

Francis JH, Iyer S, Gobin YP, Brodie SE, Abramson DH.

Ophthalmology. 2017 Oct;124(10):1548-1555. doi: 10.1016/j.ophtha.2017.04.010. Epub 2017 May 22.

PMID:
28545735
44.

Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.

Abramson DH, Fabius AW, Francis JH, Marr BP, Dunkel IJ, Brodie SE, Escuder A, Gobin YP.

Ophthalmic Genet. 2017 Jan-Feb;38(1):16-21. doi: 10.1080/13816810.2016.1244695. Epub 2017 Jan 17.

45.

Intraocular Pressure Changes Following Intravitreal Melphalan and Topotecan for the Treatment of Retinoblastoma With Vitreous Seeding.

Karl MD, Francis JH, Iyer S, Marr B, Abramson DH.

J Pediatr Ophthalmol Strabismus. 2017 May 1;54(3):185-190. doi: 10.3928/01913913-20161116-01. Epub 2017 Jan 17.

46.

Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.

Francis JH, Brodie SE, Marr B, Zabor EC, Mondesire-Crump I, Abramson DH.

Ophthalmology. 2017 Apr;124(4):488-495. doi: 10.1016/j.ophtha.2016.12.015. Epub 2017 Jan 12.

47.

Anterior Segment Retinoblastoma.

Abramson DH, Folberg R, Francis JH.

Ophthalmol Retina. 2017 Nov - Dec;1(6):561. doi: 10.1016/j.oret.2017.08.004. Epub 2017 Nov 1. No abstract available.

PMID:
31047455
48.

Update on Ophthalmic Oncology 2014: Retinoblastoma and Uveal Melanoma.

Francis JH, Levin AM, Abramson DH.

Asia Pac J Ophthalmol (Phila). 2016 Sep-Oct;5(5):368-82. doi: 10.1097/APO.0000000000000213. Review.

PMID:
27632029
49.

OCULAR PHARMACOLOGY OF CHEMOTHERAPY FOR RETINOBLASTOMA.

Schaiquevich P, Fabius AW, Francis JH, Chantada GL, Abramson DH.

Retina. 2017 Jan;37(1):1-10. doi: 10.1097/IAE.0000000000001275. Review.

PMID:
27617542
50.

Metastatic disease from uveal melanoma: treatment options and future prospects.

Carvajal RD, Schwartz GK, Tezel T, Marr B, Francis JH, Nathan PD.

Br J Ophthalmol. 2017 Jan;101(1):38-44. doi: 10.1136/bjophthalmol-2016-309034. Epub 2016 Aug 29. Review.

Supplemental Content

Loading ...
Support Center